======= FRK ======= == Gene Information == * **Official Symbol**: FRK * **Official Name**: fyn related Src family tyrosine kinase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2444|2444]] * **UniProt**: [[https://www.uniprot.org/uniprot/P42685|P42685]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FRK&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FRK|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606573|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Non-receptor tyrosine-protein kinase that negatively regulates cell proliferation. Positively regulates PTEN protein stability through phosphorylation of PTEN on 'Tyr-336', which in turn prevents its ubiquitination and degradation, possibly by reducing its binding to NEDD4. May function as a tumor suppressor. {ECO:0000269|PubMed:19345329}. |Pkinase Tyr| |SH2| |SH3 1| |Pkinase| |SH3 2| |peptidyl-tyrosine autophosphorylation| |non-membrane spanning protein tyrosine kinase activity| |extrinsic component of cytoplasmic side of plasma membrane| |specific granule lumen| |intracellular| |protein tyrosine kinase activity| |azurophil granule lumen| |peptidyl-tyrosine phosphorylation| |peptidyl-tyrosine modification| |protein autophosphorylation| |signaling receptor binding| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |leukocyte degranulation| |transmembrane receptor protein tyrosine kinase signaling pathway| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |negative regulation of cell population proliferation| |regulated exocytosis| |enzyme linked receptor protein signaling pathway| |leukocyte mediated immunity| |exocytosis| |negative regulation of transcription by RNA polymerase II| |peptidyl-amino acid modification| |leukocyte activation| |protein phosphorylation| |secretion by cell| |export from cell| |cell activation| |immune effector process| |secretion| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |phosphorylation| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |ATP binding| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |regulation of cell population proliferation| |negative regulation of gene expression| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp220|BAY-598 4μM R05 exp220]]|-1.91| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|1.76| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17915 * **Expression level (log2 read counts)**: 5.77 {{:chemogenomics:nalm6 dist.png?nolink |}}